サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1643507

医用画像診断における人工知能の世界市場

Artificial Intelligence in Medical Imaging

出版日
ページ情報
英文 199 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
医用画像診断における人工知能の世界市場
出版日: 2025年01月27日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 199 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

医用画像診断における人工知能の世界市場は2030年までに81億米ドルに達する見込み

2024年に15億米ドルと推定される医用画像診断における人工知能の世界市場は、分析期間2024年から2030年にかけてCAGR 32.9%で成長し、2030年には81億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるディープラーニング技術は、CAGR 30.1％を記録し、分析期間終了までに42億米ドルに達すると予測されます。自然言語処理（NLP）技術セグメントの成長率は、分析期間でCAGR 36.8％と推定されます。

米国市場は3億8,640万米ドルと推定、中国はCAGR31.4％で成長予測

米国の医用画像診断における人工知能市場は、2024年に3億8,640万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに12億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは31.4%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ29.7%と28.8%と予測されています。欧州では、ドイツがCAGR約23.2%で成長すると予測されています。

世界の医用画像診断における人工知能市場- 主要動向と促進要因まとめ

AIは医療画像診断にどのような革命をもたらすか？

人工知能（AI）は、診断精度を高め、ワークフローを合理化し、疾患の早期発見を可能にすることで、医療画像診断に変革をもたらしつつあります。従来の画像診断法は、手作業による解釈に頼ることが多く、時間がかかり、ばらつきが生じやすいです。AIを搭載したシステムは、画像データを卓越したスピードと精度で分析することで、こうした課題に対処し、人間の目では見逃される可能性のある異常を特定します。

膨大な医療画像のデータセットで訓練された機械学習アルゴリズムは、がん、心血管疾患、神経疾患などの病気を早期に発見することができます。例えば、放射線科のAIツールは、CTスキャン、MRI、X線を分析して腫瘍、骨折、その他の異常を特定し、診断ミスを減らして患者の転帰を改善することができます。こうしたツールは治療の質を高めるだけでなく、放射線科医の負担を軽減します。

AIはまた、患者固有の画像データを分析して病気の進行や治療への反応を予測することで、個別化医療の進歩を可能にしています。この機能は、個々の患者に最適な治療を保証し、オーダーメイドの治療戦略をサポートします。このように、医療用画像診断システムへのAIの統合は、診断における精度と効率の基準を再定義しつつあります。

医療用画像診断におけるAIの採用を促進するものは何か？

慢性疾患の増加、早期かつ正確な診断に対する需要の高まりが、医療画像診断におけるAI導入の主な推進力となっています。がん、心血管疾患、神経変性疾患などの治療には、効果的な治療のためのタイムリーな発見が必要です。AIを搭載した画像診断ツールは、これらの疾患を早期に診断するために必要な洞察をヘルスケア専門家に提供し、患者の転帰を改善し、医療費を削減します。

高度な診断ツールや電子カルテによって生成される画像データの急増も重要な要因です。AIシステムはこのデータを分析してパターンや相関関係を明らかにし、診断精度を向上させる実用的な洞察を提供します。このような機能は、放射線科医が圧倒的な業務量に直面することが多い大規模ヘルスケア施設では特に価値があります。

さらに、クラウドコンピューティングとエッジAIの進歩により、医療画像ソリューションがより身近なものとなっています。これらの技術により、医療提供者は多額のインフラ投資をすることなくAI主導の診断を活用できるようになり、地方や医療が行き届いていない地域を含む多様な医療環境でのAIツールの導入が促進されます。

AIは医療画像診断の効率とアクセシビリティを改善できるか？

AIはルーチン作業を自動化し、遠隔診断を可能にすることで、医療画像診断の効率性とアクセシビリティに革命をもたらしています。AIを搭載したシステムは、画像のセグメンテーション、アノテーション、レポート作成を自動化することでワークフローを合理化し、放射線技師が反復作業に費やす時間を削減します。この効率化により、放射線技師は複雑な症例に集中できるようになり、画像診断部門全体の生産性が向上します。

AIはまた、遠隔画像診断や遠隔診断をサポートすることで、アクセシビリティも向上させます。専門医へのアクセスが限られている地域では、AIツールが医療画像を解析して診断レポートを作成し、ヘルスケア提供のギャップを埋める。こうした機能は、タイムリーで正確な診断が人命を救う低資源環境において特に有益です。

さらにAIは、緊急の対応が必要な画像検査に優先順位をつけることで、緊急症例の迅速なトリアージを可能にしています。例えば、AIシステムは脳卒中や肺塞栓症などの重篤な状態をリアルタイムで特定し、患者が迅速な治療を受けられるようにすることができます。このような進歩は、医療画像サービスの提供を変革し、より効率的で、より多くの人々が利用しやすいものにしています。

医療画像診断におけるAI市場の成長の原動力は？

医用画像診断における人工知能市場の成長は、ヘルスケアにおける変革の可能性を反映したいくつかの重要な要因によって牽引されています。精密診断と個別化医療に対する需要の高まりは、重要な促進要因です。AIを搭載した画像診断ツールは診断精度を高め、オーダーメイドの治療計画を可能にし、現代ヘルスケアの進化するニーズに対応します。

ディープラーニングやコンピュータビジョンを含むAIの技術的進歩は、医療用画像処理システムの能力を拡大しています。これらの技術革新は疾患の検出と特徴付けを改善し、AIを放射線科医と臨床医にとって不可欠なツールにしています。さらに、CT、MRI、超音波などの画像診断モダリティとAIの統合が進むことで、この分野のイノベーションが促進されています。

AIベースの医療機器に対する規制上の支援や、価値に基づく医療への注目の高まりも市場の成長を後押ししています。政府やヘルスケア機関は、患者の転帰を改善しコストを削減するためにAIの導入を奨励しています。これらの要因は、慢性疾患の有病率の上昇やAIアルゴリズムの継続的な開発と相まって、医療画像診断におけるAI市場の急成長を後押ししており、診断とヘルスケア提供における将来の進歩の礎石として位置付けられています。

セグメント

技術（ディープラーニング技術、自然言語処理（NLP）技術、その他技術）、モダリティ（CTスキャンモダリティ、MRIモダリティ、X線モダリティ、超音波モダリティ、核画像モダリティ）、用途（神経学用途、呼吸器・呼吸器用途、整形外科用途、循環器用途、乳房スクリーニング用途、その他用途）、最終用途（病院最終用途、画像診断センター最終用途、その他最終用途）

調査対象企業の例（注目の合計25社）

  • Advanced Micro Devices, Inc.
  • Butterfly Network, Inc.
  • Canon Medical Systems USA, Inc.
  • Digital Diagnostics
  • EchoNous, Inc.
  • Enlitic
  • Exo Imaging, Inc.
  • GE Healthcare
  • HeartFlow
  • Microsoft Corporation

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP29259

Global Artificial Intelligence in Medical Imaging Market to Reach US$8.1 Billion by 2030

The global market for Artificial Intelligence in Medical Imaging estimated at US$1.5 Billion in the year 2024, is expected to reach US$8.1 Billion by 2030, growing at a CAGR of 32.9% over the analysis period 2024-2030. Deep Learning Technology, one of the segments analyzed in the report, is expected to record a 30.1% CAGR and reach US$4.2 Billion by the end of the analysis period. Growth in the Natural Language Processing (NLP) Technology segment is estimated at 36.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$386.4 Million While China is Forecast to Grow at 31.4% CAGR

The Artificial Intelligence in Medical Imaging market in the U.S. is estimated at US$386.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 31.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 29.7% and 28.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 23.2% CAGR.

Global Artificial Intelligence in Medical Imaging Market - Key Trends & Drivers Summarized

How Is AI Revolutionizing Medical Imaging Diagnostics?

Artificial Intelligence (AI) is transforming medical imaging by enhancing diagnostic accuracy, streamlining workflows, and enabling early disease detection. Traditional imaging methods often rely on manual interpretation, which can be time-consuming and prone to variability. AI-powered systems address these challenges by analyzing imaging data with exceptional speed and precision, identifying abnormalities that might be missed by human eyes.

Machine learning algorithms trained on vast datasets of medical images can detect diseases such as cancer, cardiovascular conditions, and neurological disorders at an early stage. For instance, AI tools in radiology can analyze CT scans, MRIs, and X-rays to identify tumors, fractures, and other anomalies, reducing diagnostic errors and improving patient outcomes. These tools not only enhance the quality of care but also alleviate the workload of radiologists.

AI is also enabling advancements in personalized medicine by analyzing patient-specific imaging data to predict disease progression and response to treatments. This capability supports tailored therapeutic strategies, ensuring optimal care for individual patients. The integration of AI into medical imaging systems is thus redefining the standards of precision and efficiency in diagnostics.

What Drives the Adoption of AI in Medical Imaging?

The increasing prevalence of chronic diseases and the growing demand for early and accurate diagnostics are major drivers of AI adoption in medical imaging. Conditions such as cancer, cardiovascular diseases, and neurodegenerative disorders require timely detection for effective treatment. AI-powered imaging tools provide healthcare professionals with the insights needed to diagnose these diseases at earlier stages, improving patient outcomes and reducing healthcare costs.

The surge in imaging data generated by advanced diagnostic tools and electronic health records is another critical factor. AI systems analyze this data to uncover patterns and correlations, offering actionable insights that improve diagnostic accuracy. These capabilities are particularly valuable in large healthcare facilities, where radiologists often face overwhelming workloads.

Moreover, advancements in cloud computing and edge AI are making medical imaging solutions more accessible. These technologies enable healthcare providers to leverage AI-driven diagnostics without significant infrastructure investments, facilitating the adoption of AI tools across diverse healthcare settings, including rural and underserved areas.

Can AI Improve Efficiency and Accessibility in Medical Imaging?

AI is revolutionizing efficiency and accessibility in medical imaging by automating routine tasks and enabling remote diagnostics. AI-powered systems streamline workflows by automating image segmentation, annotation, and report generation, reducing the time radiologists spend on repetitive tasks. This efficiency allows radiologists to focus on complex cases and improves overall productivity in diagnostic imaging departments.

AI also enhances accessibility by supporting teleradiology and remote diagnostics. In areas with limited access to specialists, AI tools analyze medical images and generate diagnostic reports, bridging the gap in healthcare delivery. These capabilities are particularly beneficial in low-resource settings, where timely and accurate diagnostics can save lives.

Additionally, AI is enabling faster triage of emergency cases by prioritizing imaging studies that require immediate attention. For instance, AI systems can identify critical conditions such as strokes or pulmonary embolisms in real time, ensuring that patients receive prompt treatment. These advancements are transforming the delivery of medical imaging services, making them more efficient and accessible to a broader population.

What’s Driving the Growth of the AI in Medical Imaging Market?

The growth in the Artificial Intelligence in Medical Imaging market is driven by several key factors, reflecting its transformative potential in healthcare. The rising demand for precision diagnostics and personalized medicine is a significant growth driver. AI-powered imaging tools enhance diagnostic accuracy and enable tailored treatment plans, addressing the evolving needs of modern healthcare.

Technological advancements in AI, including deep learning and computer vision, are expanding the capabilities of medical imaging systems. These innovations improve the detection and characterization of diseases, making AI an indispensable tool for radiologists and clinicians. Furthermore, the increasing integration of AI with imaging modalities such as CT, MRI, and ultrasound is driving innovation in the field.

Regulatory support for AI-based medical devices and the growing focus on value-based care are also fueling market growth. Governments and healthcare organizations are encouraging the adoption of AI to improve patient outcomes and reduce costs. These factors, combined with the rising prevalence of chronic diseases and the continuous development of AI algorithms, are propelling the rapid growth of the AI in Medical Imaging market, positioning it as a cornerstone of future advancements in diagnostics and healthcare delivery.

SCOPE OF STUDY:

The report analyzes the Artificial Intelligence in Medical Imaging market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Deep Learning Technology, Natural Language Processing (NLP) Technology, Other Technologies); Modality (CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality, Nuclear Imaging Modality); Application (Neurology Application, Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications); End-Use (Hospitals End-Use, Diagnostic Imaging Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 25 Featured) -

  • Advanced Micro Devices, Inc.
  • Butterfly Network, Inc.
  • Canon Medical Systems USA, Inc.
  • Digital Diagnostics
  • EchoNous, Inc.
  • Enlitic
  • Exo Imaging, Inc.
  • GE Healthcare
  • HeartFlow
  • Microsoft Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Economic Frontiers: Trends, Trials & Transformations
    • Artificial Intelligence in Medical Imaging - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • AI Solutions for Radiology Propel Growth in Diagnostic Accuracy and Speed
    • Integration of AI in Image Analysis Expands Opportunities for Early Disease Detection
    • AI for Cancer Imaging Bodes Well for Market Growth in Oncology Diagnostics
    • AI in MRI and CT Scan Interpretation Spurs Innovations in Neurological Assessments
    • Emerging AI Tools for Cardiovascular Imaging Highlight Market Potential
    • AI-Enhanced Imaging Workflow Automation Drives Demand in Radiology Departments
    • AI-Powered 3D Imaging Solutions Expand Addressable Market for Surgical Planning
    • Demand for AI in Teleimaging Accelerates Adoption in Remote Diagnostics
    • Advancements in AI for Image Reconstruction Propel Growth in Low-Dose Imaging
    • AI for Real-Time Tumor Detection Sustains Growth in Precision Imaging Markets
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Intelligence in Medical Imaging Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Artificial Intelligence in Medical Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Deep Learning Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Deep Learning Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Natural Language Processing (NLP) Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Natural Language Processing (NLP) Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Respiratory & Pulmonary Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Respiratory & Pulmonary Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Orthopedics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Orthopedics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Cardiology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Cardiology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Breast Screening Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Breast Screening Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Neurology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Neurology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Diagnostic Imaging Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Diagnostic Imaging Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for CT Scan Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for CT Scan Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for MRI Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 31: World 6-Year Perspective for MRI Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for X-ray Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World 6-Year Perspective for X-ray Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Ultrasound Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 35: World 6-Year Perspective for Ultrasound Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 36: World Recent Past, Current & Future Analysis for Nuclear Imaging Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 37: World 6-Year Perspective for Nuclear Imaging Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Intelligence in Medical Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Technology - Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA 6-Year Perspective for Artificial Intelligence in Medical Imaging by Technology - Percentage Breakdown of Value Sales for Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
    • TABLE 40: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Application - Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: USA 6-Year Perspective for Artificial Intelligence in Medical Imaging by Application - Percentage Breakdown of Value Sales for Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application for the Years 2025 & 2030
    • TABLE 42: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: USA 6-Year Perspective for Artificial Intelligence in Medical Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Modality - CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA 6-Year Perspective for Artificial Intelligence in Medical Imaging by Modality - Percentage Breakdown of Value Sales for CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • CANADA
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Technology - Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Canada 6-Year Perspective for Artificial Intelligence in Medical Imaging by Technology - Percentage Breakdown of Value Sales for Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
    • TABLE 48: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Application - Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Canada 6-Year Perspective for Artificial Intelligence in Medical Imaging by Application - Percentage Breakdown of Value Sales for Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application for the Years 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada 6-Year Perspective for Artificial Intelligence in Medical Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 52: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Modality - CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Canada 6-Year Perspective for Artificial Intelligence in Medical Imaging by Modality - Percentage Breakdown of Value Sales for CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • JAPAN
    • Artificial Intelligence in Medical Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Technology - Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Japan 6-Year Perspective for Artificial Intelligence in Medical Imaging by Technology - Percentage Breakdown of Value Sales for Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Application - Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan 6-Year Perspective for Artificial Intelligence in Medical Imaging by Application - Percentage Breakdown of Value Sales for Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application for the Years 2025 & 2030
    • TABLE 58: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Japan 6-Year Perspective for Artificial Intelligence in Medical Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 60: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Modality - CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Japan 6-Year Perspective for Artificial Intelligence in Medical Imaging by Modality - Percentage Breakdown of Value Sales for CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • CHINA
    • Artificial Intelligence in Medical Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Technology - Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China 6-Year Perspective for Artificial Intelligence in Medical Imaging by Technology - Percentage Breakdown of Value Sales for Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
    • TABLE 64: China Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Application - Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: China 6-Year Perspective for Artificial Intelligence in Medical Imaging by Application - Percentage Breakdown of Value Sales for Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application for the Years 2025 & 2030
    • TABLE 66: China Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: China 6-Year Perspective for Artificial Intelligence in Medical Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Modality - CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China 6-Year Perspective for Artificial Intelligence in Medical Imaging by Modality - Percentage Breakdown of Value Sales for CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • EUROPE
    • Artificial Intelligence in Medical Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 71: Europe 6-Year Perspective for Artificial Intelligence in Medical Imaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Technology - Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Europe 6-Year Perspective for Artificial Intelligence in Medical Imaging by Technology - Percentage Breakdown of Value Sales for Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Application - Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe 6-Year Perspective for Artificial Intelligence in Medical Imaging by Application - Percentage Breakdown of Value Sales for Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application for the Years 2025 & 2030
    • TABLE 76: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Europe 6-Year Perspective for Artificial Intelligence in Medical Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 78: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Modality - CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Europe 6-Year Perspective for Artificial Intelligence in Medical Imaging by Modality - Percentage Breakdown of Value Sales for CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • FRANCE
    • Artificial Intelligence in Medical Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Technology - Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France 6-Year Perspective for Artificial Intelligence in Medical Imaging by Technology - Percentage Breakdown of Value Sales for Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
    • TABLE 82: France Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Application - Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: France 6-Year Perspective for Artificial Intelligence in Medical Imaging by Application - Percentage Breakdown of Value Sales for Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application for the Years 2025 & 2030
    • TABLE 84: France Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: France 6-Year Perspective for Artificial Intelligence in Medical Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Modality - CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France 6-Year Perspective for Artificial Intelligence in Medical Imaging by Modality - Percentage Breakdown of Value Sales for CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • GERMANY
    • Artificial Intelligence in Medical Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 88: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Technology - Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Germany 6-Year Perspective for Artificial Intelligence in Medical Imaging by Technology - Percentage Breakdown of Value Sales for Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
    • TABLE 90: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Application - Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Germany 6-Year Perspective for Artificial Intelligence in Medical Imaging by Application - Percentage Breakdown of Value Sales for Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application for the Years 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany 6-Year Perspective for Artificial Intelligence in Medical Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 94: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Modality - CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Germany 6-Year Perspective for Artificial Intelligence in Medical Imaging by Modality - Percentage Breakdown of Value Sales for CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • ITALY
    • TABLE 96: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Technology - Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Italy 6-Year Perspective for Artificial Intelligence in Medical Imaging by Technology - Percentage Breakdown of Value Sales for Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Application - Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy 6-Year Perspective for Artificial Intelligence in Medical Imaging by Application - Percentage Breakdown of Value Sales for Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application for the Years 2025 & 2030
    • TABLE 100: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Italy 6-Year Perspective for Artificial Intelligence in Medical Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 102: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Modality - CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Italy 6-Year Perspective for Artificial Intelligence in Medical Imaging by Modality - Percentage Breakdown of Value Sales for CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • UNITED KINGDOM
    • Artificial Intelligence in Medical Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Technology - Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK 6-Year Perspective for Artificial Intelligence in Medical Imaging by Technology - Percentage Breakdown of Value Sales for Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
    • TABLE 106: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Application - Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 107: UK 6-Year Perspective for Artificial Intelligence in Medical Imaging by Application - Percentage Breakdown of Value Sales for Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application for the Years 2025 & 2030
    • TABLE 108: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 109: UK 6-Year Perspective for Artificial Intelligence in Medical Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Modality - CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK 6-Year Perspective for Artificial Intelligence in Medical Imaging by Modality - Percentage Breakdown of Value Sales for CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 112: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Technology - Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Rest of Europe 6-Year Perspective for Artificial Intelligence in Medical Imaging by Technology - Percentage Breakdown of Value Sales for Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
    • TABLE 114: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Application - Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Rest of Europe 6-Year Perspective for Artificial Intelligence in Medical Imaging by Application - Percentage Breakdown of Value Sales for Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application for the Years 2025 & 2030
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Europe 6-Year Perspective for Artificial Intelligence in Medical Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 118: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Modality - CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Rest of Europe 6-Year Perspective for Artificial Intelligence in Medical Imaging by Modality - Percentage Breakdown of Value Sales for CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Intelligence in Medical Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 120: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Technology - Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Medical Imaging by Technology - Percentage Breakdown of Value Sales for Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Application - Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Medical Imaging by Application - Percentage Breakdown of Value Sales for Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application for the Years 2025 & 2030
    • TABLE 124: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Medical Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 126: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Modality - CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Medical Imaging by Modality - Percentage Breakdown of Value Sales for CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Technology - Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of World 6-Year Perspective for Artificial Intelligence in Medical Imaging by Technology - Percentage Breakdown of Value Sales for Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
    • TABLE 130: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Application - Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 131: Rest of World 6-Year Perspective for Artificial Intelligence in Medical Imaging by Application - Percentage Breakdown of Value Sales for Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application for the Years 2025 & 2030
    • TABLE 132: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Rest of World 6-Year Perspective for Artificial Intelligence in Medical Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Modality - CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of World 6-Year Perspective for Artificial Intelligence in Medical Imaging by Modality - Percentage Breakdown of Value Sales for CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality for the Years 2025 & 2030

IV. COMPETITION